The Deutsche Diabetes Forschungsgesellschaft e.V. Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2015
NCT02637973
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Deutsches Diabetes-Zentrum | The Deutsche Diabetes Forschungsgesellschaft e.V.